S.Africa suspends use of AstraZeneca vaccine after trial showing limited protection
- Country:
- South Africa
South Africa will suspend use of the AstraZeneca vaccine in its immunisation programme while scientists advise on the best way to proceed, Health Minister Zweli Mkhize said on Sunday.
Mkhize was speaking after trial data showed the AstraZeneca vaccine offered only limited protection against mild disease caused by the 501Y.V2 coronavirus variant first identified in South Africa.
ALSO READ
-
AfDB selects four green hydrogen projects of $20 million grants in Africa
-
Following Money: South Africa’s Trade Gaps Point to Possible Illicit Flows
-
Chilling Discovery Near Johannesburg: Ninth Woman's Body Unveiled
-
Global Health Updates: ByteDance AI Spin-off, Cancer Drug Expansion, and Vaccine Challenges
Google News